Discovery and systematic assessment of early biomarkers that predict progression to severe COVID-19 disease
K. Hufnagel, A. Fathi, et al.
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Assessment of COVID-19 as the underlying cause of death among children and young people aged 0 to 19 years in the US
F. S, W. C, et al.
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
G. 2. D. Collaborators, D. Kanyin, et al.
Design and assessment of a teaching program to address temporal concepts in Early Childhood Education and Primary Education using stories
V. Vivas-moreno, P. Miralles-martínez, et al.
Effect of Neutralizing Monoclonal Antibody Treatment on Early Trajectories of Virologic and Immunologic Biomarkers in Patients Hospitalized With COVID-19
T. O. Jensen, G. A. Grandits, et al.
